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SUMMARY
A prospective study was carried out in the City of 
Gweru in 1988 toexamine the relationship between age 
and protection afforded measles vaccinees by the 
measles vaccine. The age group 10 months to nine 
years accounted for 240 cases or 87 pc of the 276 
measles cases reported in 1988. The disease had shifted 
towards older age groups with children aged 10 to 59 
months accounting for 105 cases or 43,7 pc and those 
aged five to nine years accounting for 135 cases or 56,3 
pc of the 240 measles cases reported in the age group 10 
months to nine years. In all the sub-age groups of the 
age group 10 months to nine years i.e. 10 to 23 months, 
24 to 35 months, 36 to 47 months etc. the proportion of 
vaccinated cases was more than that of unvaccinated 
cases and the incidence rates in the un vaccinated popu­
lation were all higher than in the vaccinated population. 
A correlation of age and relative risk (relative risk was 
calculated for each sub-age group) showed a signifi­
cant negative trend (correlation coefficient=-0,79;
p = 0,012).
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On account of the shift of the disease towards older 
age groups and a decline of relative risk as age in­
creased, the study concludes that older age groups may 
be less protected by the measles vaccine than the young 
age groups. Possible reasons for this finding are ex­
plored.
INTRODUCTION
In the City of Gweru (Zimbabwe) measles vaccination 
coverage rose from 7 pc in 1971 (when measles vacci­
nation was commenced) to 91 pc in 1989. By 1984 the 
proportion of reported measles cases who had had 
vaccination (vaccination failures) had outstripped that 
of the unvaccinated cases. In 1986 and after, the disease 
showed features of a shift towards older age groups. A 
greater proportion of measles cases now occurred after 
five years of age. In the light of these two epidemiologi­
cal occurances a study was carried out in 1988 to 
examine the relationship between age and risk of infec­
tion in the vaccinated and unvaccinated child popula­
tion.
Gweru, capital city of the Midlands province in 
Zimbabwe, has a population of 124 735 (1992 popula­
tion census). In Gweru children are vaccinated against 
measles at nine months of age with a Schwarz-type 
vaccine. Vaccinations are carried out at static primary 
care health facilities on a “supermarket” approach 
basis.
MATERIALS AND METHODS
The study was prospective in nature. Between January 
and December 1988, measles cases were identified in 
Gweru by use of a standard case definition which was 
availed to all primary health care facilities in the city, 
the city’s infectious disease hospital and personnel 
who were assigned to investigate measles cases in the 
community. Details of each identified case were en­
tered on a measles surveillance form. These details 
included the age of the person with the disease, vacci­
nation status (including age at vaccination where appli­
cable), date of commencement of the disease and its 
signs and symptoms (particularly in relation to the 
standard case definition).
In the analysis only children aged 10 months to nine 
years were considered because this group accounted 
for over 87 pc of all identified cases of measles. The 
population denominators used in calculating the inci­
dence rates for the various age groups were obtained 
from annual census surveys carried out by the Town
Clerk’s department in Gweru.
The relative risk was computed for each sub-age 
group of the 10 months to nine years age group (i.e. 10 
to 23 months, 24 to 35 months, 36 to 47 months etc.) 
and in this study it was used to define the level of 
protection among the vaccinated, or the risk of acquir­
ing infection in the non-vaccinated.
Limitations of the study:
1. There were problems with definition of vaccina­
tion status of cases, particularly where there was no 
documentary proof. It was therefore decided that in 
the absence of documentary proof (child health 
card) such acase of measles is deemed unvaccinated.
2. An effort was made to investigate measles cases in 
the community to avoid missing unreported cases 
(including deaths). There is no doubt that this was 
met with some success, but it is equally possible 
that some cases could have been missed in these 
investigations.
RESULTS
In 1988, 276 cases of measles were reported from 
Gweru of which 240 or 87 pc were aged 10 months to 
nine years. In the age group 10 months to nine years 
105 cases or 43,7 pc were aged 10 to 59 months while 
135 cases or 56,3 pc were aged five to nine years. In the 
same age group (i.e. 10 months to nine years) 158 cases 
or 65,8 pc of cases were vaccinated while 82 cases or
Table I: Age and vaccination status o f  measles cases 
reported from the City o f  Gweru in 1988.
Age (months) Unvaccinated Vaccinated Total
0-9 19 0 19
10-23 14 25 39
24-35 11 14 25
36-47 5 13 18
48-59 5 18 23
60-71 8 23 31
72-83 18 30 48
84-95 7 15 22
96-107 7 16 23
108-119 7 4 11
120-t- 14 3 17
Total 115 161 276
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TableII:Incidence ratesinunvaccinatedandvaccinated 
children (per 100 000 population) and relative risk 
calculations fo r  age group 10 months to nine years.
Age Incidence rates Incidence rates Relative
(months) in the unvacdnated in the vaccinated risk
(/100 000 population) (/100 000 population)
10-23 5 785 1 041 5,6
24-35 2 083 362 5,8
36-47 1 577 334 4,7
48-59 1 082 482 2,2
60-71 1 732 679 2,6
72-83 2 446 1 218 2,0
84-95 876 694 1,3
96-107 1 032 745 1,4
108-119 766 246 3,1
34,2 pc were not vaccinated, (see Table I).
In all the sub-age groups of the 10 months to nine 
years age group i.e. 10 to 23 months, 24 to 53 months 
etc. (see Table II) the incidence rates in the un vaccinated 
population were more than those in the vaccinated 
population.
The relative risk that was calculated for each sub-age 
group tended to decline as age increased, (see Table II) 
Correlation of age and relative risk showed a signifi­
cant negative trend (correlation coefficient = -0,79;
Figure 1: Relative risk (RR) vs age. RR o f acquiring 
measles.
CityofGweru 1988: RR o f vaccinated vs unvaccinated 
child populations.
p ^  0,012). (see Figure I).
DISCUSSION
An increase in the proportion (but not the rate) of cases 
which occur among children previously immunised is 
a consequence of high vaccination coverage.1-2'3 The 
findings in the Gweru study confirm this observation. 
In this study, in all sub-age groups of the age group 10 
months to nine years, the proportion of vaccinated 
cases was more than that of unvaccinated cases but the 
incidence rates in the unvaccinated population were 
always higher than in the vaccinated population.
A shift of the disease towards older children has been 
observed in this study. The shift of the disease towards 
older children or even young adults is said to be an 
expected consequence of moderately high vaccination 
coverage, in immunisation programmes whose target 
age group has been under two years of age (under one 
year of age in most developing countries).1-3 The as­
sumption in this statement, however, is that by sustain­
ing high vaccination coverages in the young age groups, 
the older children and young adults who have not been 
vaccinated are a susceptible population to whom the 
disease would tend to shift.
The findings in the Gweru study do not concur with 
this observation. In Gweru in 1988 the coverage in the 
age group 10 months to nine years was 85 pc. Further, 
as indicated earlier, the finding of a high proportion of 
vaccinated cases (higher than the proportion of 
unvaccinated cases) in all sub-age groups of the 10 
months to nine years age group is itself an indication 
of high vaccination coverage in this age group which 
accounted for 87 pc of all cases in Gweru in 1988.
In this study correlation of age and relative risk 
seems to strongly suggest that the protection afforded 
vaccinees by the measles vaccine declines with age. 
One reason for this occurance could be that children 
who were five years of age and older in 1988 would 
have been vaccinated at a time when the more heat- 
stable measles vaccines were not available, and conse­
quently the efficacy of the vaccine could have been 
affected by cold chain failure.4-3
Recent measles vaccine efficacy studies carried out 
in the City of Harare (Zimbaowe), Muyinga in Burundi 
and a few other countries on the African continent have 
found efficacies below 80 pc even where the cold chain 
has been managed properly ,5-6-7 On account of these
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findings it has been concluded that in developing 
countries measles vaccine efficacy is lower than in 
developed countries on account of the effect of prena- 
tally acquired maternal antibodies which interfere with 
sero-conversion at the time of vaccination at nine 
monthsofage.5,8The WorldHealthOrganisation (WHO) 
has warned that even a vaccination coverage of 100 pc 
with an 80 pc effective vaccine leaves 20 pc of vaccine 
recipients susceptible to measles, permitting continued 
transmission in the community.910 Thus it could well be 
that the shift of the disease towards older age groups 
observed in the Gweru study represents an accumula­
tion of vaccination failures (susceptibles) emanating 
from a low vaccine efficacy. This is supported in this 
study by findings of low relative risks for older age 
groups.
Another phenomenon which could lead to the shift 
of the disease towards older age groups is that of 
secondary vaccination failures (vaccinees who initially 
sero-convert and with time revert to a sero-negative 
state). 1112 A study that was carried out in the United 
States of America has shown that up to 7 pc of measles 
cases could be attributed to secondary vaccination 
failures.11 In the Gweru study it is not clear what 
contribution secondary vaccination failures could be 
making in the transmission of measles in the older age 
groups.
Conclusion: 1. The protection afforded measles 
vaccinees seems to decline with age. There is therefore 
a distinct possibil ity that older age groups could sustain 
measles transmission in the community even at high 8. 
vaccination coverages. There is probably, therefore, an 
urgent need to work out modalities to boost protection 9. 
in older children to halt their role as a vehicle for 
transmission, in order to break measles transmission 10. 
cycles. This is particularly important when cognisance 
is taken of the fact that older age groups (five to nine 
years of age) now contribute 60 pc of reported measles 
cases.
2. In the light of the findings of this study it would be 
useful for Zimbabwe to cany out further studies in 
different settings to establish whether the risk of infec­
tion with measles increases with age, even at high 
vaccination coverages in the older age groups. If it is 
proven that such an occurrence does exist it would be 
important to identify the factors which are responsible
for the occurrence in order to rectify the problem of
measles transmission in the older age groups.
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